IRON · Disc Medicine, Inc.
$82.67
+0.26 (+0.32%)
At close · Aug 26
Market Cap
$3.16B
Shares
38.39M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$82.67
Open$82.28
Day$81.54–83.63
52W close$55.95–94.11
Avg vol 30d346K
Short int7.3M · 19.1% float · 24.8d
Short vol48%
Last earningsJul 30, 2026
DataDec 2022–Aug 2026
Filing10-Q · Jul 30
Raw chart and full-history price indicators begin at the captured split on Dec 30, 2022; bars on opposite sides are not compared.
Up next
Next earnings call
Oct 27, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
+8%
above
RSI (14)
64
neutral
MACD trend
Positive
52-week position
70%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+12%
trailing
6-month return
+37%
trailing
YTD return
+4%
this year
Relative strength
+25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $76 › 200d $74 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +41 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
19.12% of float · ▼ -0.7% MoM · 24.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
221 holders — near 3-yr high, broad support
Squeeze score
77
high risk · 0–100
Fundamentals
EPS growth
−52%
Y/Y
Free cash flow
$-181.3M
Balance sheet
$62.0M
net cash
Quant / Vol
risk profile
Volatility
53%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
3.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
64
Neutral
MACD trend
Positive
Bullish
52-week position
70%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $76 › 200d $74 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +41 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
19.12% of float · ▼ -0.7% MoM · 24.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
221 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $56
Now $83 · 70%
Range high $94
vs 200-day avg +11%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IRON
this stock
Disc Medicine, Inc.
|
$3.16B | +4.1% | — | — | 19.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.79B | +20.7% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.89B | +5.6% | +20.8% | 20.2 | 2.3% |
|
ARGX
Argenx SE
|
$63.81B | +24.5% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$60.07B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Dec 30, 2022; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IRON | +2.9% | +12.2% | +37.0% | +7.4% | +4.1% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +3.3% | +7.2% | +24.6% | +4.8% | -8.2% |
Key facts
CIK
1816736
CUSIP
254604101
13F (30d)
201 filings
200 filers
Visit website
Investor relations